Top compounds associated with response to CTC-360G5.8


Feature Type Standardized
Nominal ANOVA
mRNA Bortezomib CTRPv2 pan-cancer AAC -0.057 0.1
mRNA JW-480 CTRPv2 pan-cancer AAC 0.061 0.1
mRNA momelotinib CTRPv2 pan-cancer AAC 0.056 0.1
mRNA BRD-K28456706 CTRPv2 pan-cancer AAC 0.059 0.1
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.056 0.1
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.058 0.1
mRNA pluripotin CTRPv2 pan-cancer AAC 0.056 0.1
mRNA ouabain CTRPv2 pan-cancer AAC 0.055 0.1
mRNA ISOX CTRPv2 pan-cancer AAC 0.05 0.1
mRNA Cytarabine CTRPv2 pan-cancer AAC 0.044 0.1
Download CSV